syre-20240807

0001636282-24-000058.txt : 20240808 0001636282-24-000058.hdr.sgml : 20240808 20240807185303 ACCESSION NUMBER: 0001636282-24-000058 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240807 ITEM INFORMATION: Other Events FILED AS OF DATE: 20240808 DATE AS OF CHANGE: 20240807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Spyre Therapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 241185458 BUSINESS ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 6176515940 MAIL ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: Aeglea BioTherapeutics, Inc. DATE OF NAME CHANGE: 20150311 8-K/A 1 syre-20240807.htm 8-K syre-20240807

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_______________________________________________________

FORM 8-K/A

(Amendment No. 1)

_______________________________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 7, 2024

_______________________________________________________

SPYRE THERAPEUTICS, INC.

(Exact name of Registrant as Specified in Its Charter)

_______________________________________________________


Delaware	001-37722	46-4312787
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

221 Crescent Street Building 23 Suite 105
Waltham, MA		02453
(Address of Principal Executive Offices)		(Zip Code)


Registrant’s Telephone Number, Including Area Code: 617 651-5940


Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

_______________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


o			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading
Symbol(s)

Name of each exchange on which registered

Common Stock, $0.0001 Par Value Per Share

SYRE

The Nasdaq Stock Market LLC

(Nasdaq Global Select Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

EXPLANATORY NOTE

On August 7, 2024, Spyre Therapeutics, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original 8-K”) with respect to the Company's results of operations or financial condition for the quarter ended June 30, 2024. This Form 8-K/A is being filed solely for the purpose of correcting a clerical error with respect to the date of report on the Cover Page of the Original 8-K. The Original 8-K is hereby amended to correctly disclose the date of report on the Cover Page as August 7, 2024. This amendment contains only the Cover Page to this Form 8‑K/A, this Explanatory Note and the Signature Page. Except for this correction, this amendment does not modify or update any disclosure contained in the Original Filing or its exhibits and should be read in conjunction with the Original Filing and its exhibits.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


			SPYRE THERAPEUTICS, INC.

Date:	August 7, 2024	By:	/s/ Scott Burrows
			Scott Burrows Chief Financial Officer

EX-101.SCH 2 syre-20240807.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 syre-20240807_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Amendment Description Amendment Description Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Entity Address, City or Town Entity Address, City or Town Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Cover [Abstract] Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Document Type Document Type Amendment Flag Amendment Flag Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, Address Line Three Entity Registrant Name Entity Registrant Name EX-101.PRE 4 syre-20240807_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover Page	Aug. 07, 2024
Cover [Abstract]
Document Type	8-K/A
Entity Registrant Name	SPYRE THERAPEUTICS, INC.
Entity Incorporation, State or Country Code	DE
Entity File Number	001-37722
Entity Tax Identification Number	46-4312787
Entity Address, Address Line One	221 Crescent Street
Entity Address, Address Line Two	Building 23
Entity Address, Address Line Three	Suite 105
Entity Address, City or Town	Waltham
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02453
City Area Code	617
Local Phone Number	651-5940
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, $0.0001 Par Value Per Share
Trading Symbol	SYRE
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false
Amendment Flag	true
Entity Central Index Key	0001636282
Document Period End Date	Aug. 07, 2024
Amendment Description	On August 7, 2024, Spyre Therapeutics, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original 8-K”) with respect to the Company's results of operations or financial condition for the quarter ended June 30, 2024. This Form 8-K/A is being filed solely for the purpose of correcting a clerical error with respect to the date of report on the Cover Page of the Original 8-K. The Original 8-K is hereby amended to correctly disclose the date of report on the Cover Page as August 7, 2024. This amendment contains only the Cover Page to this Form 8‑K/A, this Explanatory Note and the Signature Page. Except for this correction, this amendment does not modify or update any disclosure contained in the Original Filing or its exhibits and should be read in conjunction with the Original Filing and its exhibits.

EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 1 25 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://spyre.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports syre-20240807.htm syre-20240807.xsd syre-20240807_lab.xml syre-20240807_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "syre-20240807.htm": { "nsprefix": "syre", "nsuri": "http://spyre.com/20240807", "dts": { "inline": { "local": [ "syre-20240807.htm" ] }, "schema": { "local": [ "syre-20240807.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "syre-20240807_lab.xml" ] }, "presentationLink": { "local": [ "syre-20240807_pre.xml" ] } }, "keyStandard": 25, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 26, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 25 }, "report": { "R1": { "role": "http://spyre.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "syre-20240807.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "syre-20240807.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Description", "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Three", "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://spyre.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001636282-24-000058-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001636282-24-000058-xbrl.zip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syre-20240807_htm.xml IDEA: XBRL DOCUMENT 0001636282 2024-08-07 2024-08-07 true 0001636282 8-K/A 2024-08-07 SPYRE THERAPEUTICS, INC. DE 001-37722 46-4312787 221 Crescent Street Building 23 Suite 105 Waltham MA 02453 617 651-5940 false false false false Common Stock, $0.0001 Par Value Per Share SYRE NASDAQ false On August 7, 2024, Spyre Therapeutics, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original 8-K”) with respect to the Company's results of operations or financial condition for the quarter ended June 30, 2024. This Form 8-K/A is being filed solely for the purpose of correcting a clerical error with respect to the date of report on the Cover Page of the Original 8-K. The Original 8-K is hereby amended to correctly disclose the date of report on the Cover Page as August 7, 2024. This amendment contains only the Cover Page to this Form 8‑K/A, this Explanatory Note and the Signature Page. Except for this correction, this amendment does not modify or update any disclosure contained in the Original Filing or its exhibits and should be read in conjunction with the Original Filing and its exhibits.